Skip to main content
. 2021 Mar 30;45(8):2463–2470. doi: 10.1007/s00268-021-06036-0

Table 1.

Patient and pathology characteristics

Surgery, no. (%)a
Characteristics, no. (%) Open (n = 342) Laparoscopic (n = 140) p value
Diagnosis year
2010–2012 169 (49) 65 (46) 0.55
2013–2015 173 (51) 75 (54)
Treatment centerb 335 135
Regional hospital 238 (71) 111 (82) 0.012
Academic center 97 (29) 24 (18)
Sex
Male 197 (58) 60 (43) 0.003
Age, years, mean (SD) 64 (12) 60 (12) 0.009
Tumor grade: no evaluable 341 138
Grade 1 270 (79) 110 (80) 0.90
Grade 2 71 (21) 28 (20)
Clinical TNM classificationb
registered cT stage 88 33  < 0.001
cT4 26 (30) 4 (12)
registered cN stage 259 109  < 0.001
cN1-2 165 (64) 37 (34)
registered cM stage 341 139  < 0.001
cM1 140 (41) 28 (20)
Pathological T classificationb 320 133
pT1 8 (2) 20 (15)  < 0.001
pT2 31 (10) 20 (15)
pT3 169 (53) 56 (42)
pT4 112 (35) 37 (28)
Pathological N classificationb 296 123
pN0 45 (15) 24 (20) 0.018
pN1 198 (67) 90 (73)
pN2 53 (18) 9 (7)
Pathological M classificationb
pM1 112 (33) 28 (20) 0.005
Multifocal tumors 81 (24) 19 (14) 0.014
Size of (largest) primary tumor, mm, mean (SD) 21 (10) 18 (10) 0.007
Lymph nodes
Number of examined LNs, mean (SD) 12 (10) 11 (7) 0.81
Number of tumor positive LNs, mean (SD) 3 (4) 3 (3) 0.43
Disease stageb 312 124
Stage I-II 25 (8) 17 (14) 0.012
Stage III 175 (56) 79 (64)
Stage IV 112 (36) 28 (22)
Resection margin 300 118
R0 244 (81) 105 (89) 0.06
R1/2 56 (19) 13 (11)
Conversion ratec 8/22 (36)
30-day mortality 16 (5) 3 (2) 0.19

aUnless stated otherwise

bData are reported for evaluable cases

cConversion rates were only reported in 2015, during which 22 laparoscopic resections were performed

SD Standard deviation, mm millimeter, LN Lymph node